Jury Hits Pioglitazone Makers With $9 Billion in DamagesJury Hits Pioglitazone Makers With $9 Billion in Damages

Drugmakers Takeda Pharmaceutical Co. And Elli Lilly and Co. promised to appeal a $9 billion award when a federal jury found they had concealed cancer risks of pioglitazone. Medscape Medical News
Source: Medscape Business of Medicine Headlines - Category: Pharmaceuticals Tags: Diabetes & Endocrinology News Source Type: news